The estimated Net Worth of Mark J Brooks is at least $19.3 Milione dollars as of 24 March 2022. Mr. Brooks owns over 3,690 units of Centene stock worth over $11,296,380 and over the last 8 years he sold CNC stock worth over $3,594,806. In addition, he makes $4,410,000 as Executive Vice President e Chief Information Officer at Centene.
Sign up
Mr. Brooks CNC stock SEC Form 4 insiders trading
Mark has made over 11 trades of the Centene stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 3,690 units of CNC stock worth $305,200 on 24 March 2022.
The largest trade he's ever made was selling 15,000 units of Centene stock on 7 May 2021 worth over $1,020,000. On average, Mark trades about 644 units every 29 days since 2016. As of 24 March 2022 he still owns at least 153,755 units of Centene stock.
You can see the complete history of Mr. Brooks stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mark Brooks biography
Mark J. Brooks is Executive Vice President, Chief Information Officer of the Company. Mr. Brooks has served as our Executive Vice President and Chief Information Officer since November 2017. From April 2016 to November 2017, he served as Senior Vice President and Chief Information Officer. Prior to joining Centene, he served as the Chief Information Officer at Health Net from 2012 to 2016.
What is the salary of Mark Brooks?
As the Executive Vice President e Chief Information Officer of Centene, the total compensation of Mark Brooks at Centene is $4,410,000. There are 5 executives at Centene getting paid more, with Michael Neidorff having the highest compensation of $26,438,400.
How old is Mark Brooks?
Mark Brooks is 50, he's been the Executive Vice President e Chief Information Officer of Centene since 2017. There are 23 older and 7 younger executives at Centene. The oldest executive at Centene Corp. is Robert Ditmore, 86, who is the Presiding Independent Director.
Insiders trading at Centene
Over the last 21 years, insiders at Centene have traded over $221,714,329 worth of Centene stock and bought 119,005 units worth $6,904,837 . The most active insiders traders include Frederick H Eppinger, Michael F Neidorff e Edward L Cahill. On average, Centene executives and independent directors trade stock every 18 days with the average trade being worth of $1,257,880. The most recent stock trade was executed by Christopher J Coughlin on 14 May 2024, trading 878 units of CNC stock currently worth $67,387.
What does Centene do?
centene corporation, a fortune 500 company, is a diversified, multi-national healthcare enterprise that provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. many receive benefits provided under medicaid, including the state children's health insurance program (chip), as well as aged, blind or disabled (abd), foster care and long term care (ltc), in addition to other state-sponsored/hybrid programs, and medicare (special needs plans). the company operates local health plans and offers a range of health insurance solutions. it also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health management, care management software, correctional healthcare services, dental benefits management, in-home health services, life and health management, managed vision, pharmacy benefits management, specialty pharmacy and telehealth services.
What does Centene's logo look like?
Complete history of Mr. Brooks stock trades at Centene e Reinsurance Of America
Centene executives and stock owners
Centene executives and other stock owners filed with the SEC include:
-
Michael Neidorff,
Chairman of the Board, President, Chief Executive Officer -
Jeffrey Schwaneke,
Chief Financial Officer, Executive Vice President, Treasurer -
Brandy Burkhalter,
Executive Vice President - Operations -
Michael Frederic Neidorff,
Chairman & CEO -
Jesse Hunter,
Executive Vice President and Chief Strategy Officer -
Mark Brooks,
Executive Vice President, Chief Information Officer -
Jeffrey Alan Schwaneke CPA, CPA,
Exec. VP, CFO & Treasurer -
Keith Williamson,
Executive Vice President, General Counsel, Secretary -
Brandy Lynn Burkhalter,
Exec. VP -
Mark J. Brooks,
Exec. VP & Chief Information Officer -
Frederick Eppinger,
Independent Director -
John Roberts,
Independent Director -
Robert Ditmore,
Presiding Independent Director -
David Steward,
Independent Director -
Tommy Thompson,
Independent Director -
Jessica Blume,
Independent Director -
Orlando Ayala,
Independent Director -
Lori Robinson,
Independent Director -
Richard Gephardt,
Independent Director -
William Trubeck,
Independent Director -
H. James Dallas,
Independent Director -
Jennifer Gilligan,
Senior Vice President of Investor Relations -
Christopher Koster,
Senior Vice President, General Counsel, Secretary -
Christopher Isaak,
Senior Vice President, Corporate Controller and Chief Accounting Officer -
Jonathan Dinesman,
Executive Vice President - Government Relations -
Kenneth Burdick,
Executive Vice President - Markets & Products -
H. Robert Sanders,
Executive Vice President of Human Resources -
Shannon Bagley,
Executive Vice President of Human Resources -
David Thomas,
Executive Vice President - Marketing -
Katie Nicole Casso,
Sr. VP, Chief Accounting Office & Corp. Controller -
Christopher Andrew Koster,
Sr. VP, Gen. Counsel & Sec. -
Katie Casso,
Sr. VP, Chief Accounting Office & Corp. Controller -
Andrew Lynn Asher,
Exec. VP & CFO -
Brent Davis Layton,
Pres & COO -
Sarah M. London,
Pres of Health Care Enterprises & Exec. VP of Advanced Technology & Vice Chairman -
Patrick John Rooney,
Sr. VP of Health Plans -
Matthew Snyder,
Sr. VP of Internal Audit, Compliance & Risk Management -
Christopher Russell Isaak B.B.A., CPA,
Sr. VP, Corp. Controller & Chief Accounting Officer -
Monte E Ford,
Director -
Cynthia J Brinkley,
EVP, International Operations -
Christopher D Bowers,
EVP, Markets -
Carol Goldman,
Sr VP Chief Admin Officer -
Kenneth Rone Baldwin,
EVP, Insurance Group -
James E Murray,
EVP, Chief Operating Officer -
Donald G Imholz,
SVP, Chief Information Officer -
William Scheffel,
Senior VP and Controller -
Pamela A Joseph,
Director -
Vicki B Escarra,
Director -
Leslie V Norwalk,
Director -
Christopher J Coughlin,
Director -
Theodore R. Ii Samuels,
Director -
Wayne S De Veydt,
Director -
Catherine M Halverson,
Senior VP Business Development -
Edmund E Kroll,
SVP Fin & Investor Relations -
Brian G Spanel,
Senior Vice President and CIO -
Karen Bedell,
SVP New Bus Integ & Develop -
Robert T Hitchcock,
EVP Health Plans -
Cary Hobbs,
Sr VP Strategy and Imp. -
Marie J Glancy,
VP Government Relations -
Jason M Harrold,
SVP, Specialty Business Unit -
Karey L Witty,
Senior Vice President and CFO -
J Per Brodin,
Senior Vice President and CFO -
Eric Slusser,
Executive VP & CFO -
Patti Darnley,
Sr. VP of Operations -
Lisa M Wilson,
VP Investor Relations -
Mark W Eggert,
Executive VP, Health Plans -
Mary V Mason,
SVP & Chief Medical Officer -
Edward L Cahill,
Director -
Frederick J Manning,
Executive Vice President -
Richard P Wiederhold,
Director -
James D Jr Donovan,
Senior VP Product Development -
Steve Bartlett,
Director -
C David Minifie,
EVP, Chief Marketing Officer -
Glendon A Schuster,
Senior VP and CIO -
Samuel E Bradt,
Director -
Antonette Simonetti,
SVP, Public Affairs -
Joseph P Jr Drozda,
Executive VP Operations -
John Tadich,
Senior VP, Specialty Companies -
Claire W Johnson,
Director -
Dan Paquin,
Sr. VP New Plan Implementation -
Andrew Lynn Asher,
Chief Financial Officer -
Susan Raye Smith,
Chief Operating Officer -
Brent D Layton,
President & COO -
Sarah London,
Chief Executive Officer -
Colin A Toney,
EVP, Mergers & Acquisitions -
Katie Casso,
Corporate Controller & CAO -
Kenneth J Fasola,
President